Other papers submitted by: Dr Pei-Yang Lin

open access to scientific and medical research

News:

Expressions of interest for Editor-in-Chief - the International Medical Case Reports Journal Read more

Back to User profile » Dr Pei-Yang Lin

Paper published by Dr Pei-Yang Lin:

Original Research

Highly-accessed

Serum miR-4530 sensitizes breast cancer to neoadjuvant chemotherapy by suppressing RUNX2

Wang XX, Ye FG, Zhang J, Li JJ, Chen QX, Lin PY, Song CG

Cancer Management and Research 2018, 10:4393-4400

Published Date: 9 October 2018